Literature DB >> 19268036

Neurometabolic disorders and dysfunction in autism spectrum disorders.

Nassim Zecavati1, Sarah J Spence.   

Abstract

The cause of autism remains largely unknown because it is likely multifactorial, arising from the interaction of biologic, genetic, and environmental factors. The specific role of metabolic abnormalities also is largely unknown, but current research may provide insight into the pathophysiologic underpinnings of autism, at least in some patients. We review a number of known neurometabolic disorders identified as having an autistic phenotype. We also discuss the possible involvement of mitochondrial disorders and dysfunction as well as a theory regarding an increased vulnerability to oxidative stress, by which various environmental toxins produce metabolic alterations that impair normal cellular function. Finally, we review various strategies for metabolic work-up and treatment. Accurate diagnosis of neurometabolic disorders and a broader understanding of underlying metabolic disturbance even in the absence of known disease have important implications both for individual patients and for research into the etiology of autism.

Entities:  

Mesh:

Year:  2009        PMID: 19268036     DOI: 10.1007/s11910-009-0021-x

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  40 in total

1.  Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system.

Authors:  R A Wevers; S I Hansen; J L van Hellenberg Hubar; J Holm; M Høier-Madsen; P J Jongen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

2.  Altered vascular phenotype in autism: correlation with oxidative stress.

Authors:  Yuemang Yao; William J Walsh; Woody R McGinnis; Domenico Praticò
Journal:  Arch Neurol       Date:  2006-08

Review 3.  Metals, toxicity and oxidative stress.

Authors:  M Valko; H Morris; M T D Cronin
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 4.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

5.  Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.

Authors:  P L Pearl; K M Gibson; M T Acosta; L G Vezina; W H Theodore; M A Rogawski; E J Novotny; A Gropman; J A Conry; G T Berry; M Tuchman
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

Review 6.  Should autistic children be evaluated for mitochondrial disorders?

Authors:  Tally Lerman-Sagie; Esther Leshinsky-Silver; Nathan Watemberg; Dorit Lev
Journal:  J Child Neurol       Date:  2004-05       Impact factor: 1.987

7.  Detection of phenylketonuria in autistic and psychotic children.

Authors:  T L Lowe; K Tanaka; M R Seashore; J G Young; D J Cohen
Journal:  JAMA       Date:  1980-01-11       Impact factor: 56.272

8.  The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli-Opitz syndrome) to neurosteroid production.

Authors:  Josep Marcos; Li-Wei Guo; William K Wilson; Forbes D Porter; Cedric Shackleton
Journal:  Steroids       Date:  2004-01       Impact factor: 2.668

9.  Recurrence of the R408W mutation in the phenylalanine hydroxylase locus in Europeans.

Authors:  R C Eisensmith; A A Goltsov; C O'Neill; L A Tyfield; E I Schwartz; A I Kuzmin; S S Baranovskaya; G L Tsukerman; E Treacy; C R Scriver
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Low-level environmental lead exposure and children's intellectual function: an international pooled analysis.

Authors:  Bruce P Lanphear; Richard Hornung; Jane Khoury; Kimberly Yolton; Peter Baghurst; David C Bellinger; Richard L Canfield; Kim N Dietrich; Robert Bornschein; Tom Greene; Stephen J Rothenberg; Herbert L Needleman; Lourdes Schnaas; Gail Wasserman; Joseph Graziano; Russell Roberts
Journal:  Environ Health Perspect       Date:  2005-07       Impact factor: 9.031

View more
  27 in total

1.  Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort.

Authors:  Anita Lakatos; Olga Derbeneva; Danny Younes; David Keator; Trygve Bakken; Maria Lvova; Marty Brandon; Guia Guffanti; Dora Reglodi; Andrew Saykin; Michael Weiner; Fabio Macciardi; Nicholas Schork; Douglas C Wallace; Steven G Potkin
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

2.  Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism.

Authors:  Stepan Melnyk; George J Fuchs; Eldon Schulz; Maya Lopez; Stephen G Kahler; Jill J Fussell; Jayne Bellando; Oleksandra Pavliv; Shannon Rose; Lisa Seidel; David W Gaylor; S Jill James
Journal:  J Autism Dev Disord       Date:  2012-03

Review 3.  Improving the prediction of response to therapy in autism.

Authors:  Stephen Bent; Robert L Hendren
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 4.  Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

5.  Mouse models of autism: testing hypotheses about molecular mechanisms.

Authors:  Florence I Roullet; Jacqueline N Crawley
Journal:  Curr Top Behav Neurosci       Date:  2011

6.  Autism spectrum disorder in a child with propionic acidemia.

Authors:  M Al-Owain; N Kaya; H Al-Shamrani; A Al-Bakheet; A Qari; S Al-Muaigl; M Ghaziuddin
Journal:  JIMD Rep       Date:  2012-03-31

Review 7.  Pathologies in functional connectivity, feedback control and robustness: a global workspace perspective on autism spectrum disorders.

Authors:  James F Glazebrook; Rodrick Wallace
Journal:  Cogn Process       Date:  2014-10-18

Review 8.  Autism spectrum disorder: advances in evidence-based practice.

Authors:  Evdokia Anagnostou; Lonnie Zwaigenbaum; Peter Szatmari; Eric Fombonne; Bridget A Fernandez; Marc Woodbury-Smith; Jessica Brian; Susan Bryson; Isabel M Smith; Irene Drmic; Janet A Buchanan; Wendy Roberts; Stephen W Scherer
Journal:  CMAJ       Date:  2014-01-13       Impact factor: 8.262

9.  Mitochondrial dysfunction in autism.

Authors:  Cecilia Giulivi; Yi-Fan Zhang; Alicja Omanska-Klusek; Catherine Ross-Inta; Sarah Wong; Irva Hertz-Picciotto; Flora Tassone; Isaac N Pessah
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

10.  Using whole-exome sequencing to identify inherited causes of autism.

Authors:  Timothy W Yu; Maria H Chahrour; Michael E Coulter; Sarn Jiralerspong; Kazuko Okamura-Ikeda; Bulent Ataman; Klaus Schmitz-Abe; David A Harmin; Mazhar Adli; Athar N Malik; Alissa M D'Gama; Elaine T Lim; Stephan J Sanders; Ganesh H Mochida; Jennifer N Partlow; Christine M Sunu; Jillian M Felie; Jacqueline Rodriguez; Ramzi H Nasir; Janice Ware; Robert M Joseph; R Sean Hill; Benjamin Y Kwan; Muna Al-Saffar; Nahit M Mukaddes; Asif Hashmi; Soher Balkhy; Generoso G Gascon; Fuki M Hisama; Elaine LeClair; Annapurna Poduri; Ozgur Oner; Samira Al-Saad; Sadika A Al-Awadi; Laila Bastaki; Tawfeg Ben-Omran; Ahmad S Teebi; Lihadh Al-Gazali; Valsamma Eapen; Christine R Stevens; Leonard Rappaport; Stacey B Gabriel; Kyriacos Markianos; Matthew W State; Michael E Greenberg; Hisaaki Taniguchi; Nancy E Braverman; Eric M Morrow; Christopher A Walsh
Journal:  Neuron       Date:  2013-01-23       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.